Four things to know:
1. HCA said in a Securities and Exchange Commission filing that it expects net proceeds from the offering of $4.91 billion.
2. The company said the proceeds will be used for general corporate purposes and to refinance existing debt coming due over the next few years.
3. HCA said $2 billion of the senior secured notes will mature in 2029, $1 billion will mature in 2039 and the remaining $2 billion will mature in 2049.
4. Moody’s Investors Service assigned a “Baa3” rating to HCA’s new senior secured notes. “Moody’s expects this transaction to reduce interest expense and extend the company’s maturity profile,” the credit rating agency said in a June 5 press release.
More articles on healthcare finance:
Medicare termination forces Kentucky hospital to cut workforce by half
Trinity Health’s operating income sinks 44% in first 9 months of fiscal year
13 health systems with strong finances
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
